Milestone for Crispr: First-of-Its-Kind Gene Editing Treatment Successfully Passes Clinical Trial

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

CRISPR Breakthrough Brings First In-Body Cure With Lonvo-Z

A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...

What's the next big thing after GLP-1 drugs? CRISPR Therapeutics may have the answer.

The biotech's candidate may treat a great number of illnesses that have one thing in common.
techtimes

CRISPR Biosensors Transform Real-Time Health Monitoring With Cutting-Edge Biotech Innovation

CRISPR biosensors are transforming healthcare by detecting biomarkers at attomolar sensitivity, enabling real-time health monitoring through wearable patches and implantable sensors. They continuously ...

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a ...
Seeking Alpha

CRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025

ZUG, Switzerland and BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
The Motley Fool

The 3 Things That Matter for CRISPR Therapeutics Now

CRISPR Therapeutics’ gene-editing treatments are highly customized and shockingly expensive. The market is watching to see if the underlying science can be applied to treat many diseases. The company ...